RxSight annual gross margin
2020
2021
2022
2023
2024
2025
RxSight's gross margin was 76.60% for fiscal 2025.
View full RxSight company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 76.60% | +5.89 pp |
| 2024 | 2024-12-31 | 70.71% | +10.35 pp |
| 2023 | 2023-12-31 | 60.36% | +16.84 pp |
| 2022 | 2022-12-31 | 43.52% | +23.53 pp |
| 2021 | 2021-12-31 | 19.99% | +8.38 pp |
| 2020 | 2020-12-31 | 11.62% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | 76.06% | +1.31 pp |
| Q4 2025 | 2025-12-31 | 77.48% | +5.89 pp |
| Q3 2025 | 2025-09-30 | 79.85% | +8.44 pp |
| Q2 2025 | 2025-06-30 | 74.89% | +5.38 pp |
| Q1 2025 | 2025-03-31 | 74.76% | +4.67 pp |
| Q4 2024 | 2024-12-31 | 71.59% | +9.82 pp |
| Q3 2024 | 2024-09-30 | 71.42% | +9.56 pp |
| Q2 2024 | 2024-06-30 | 69.51% | +11.77 pp |
| Q1 2024 | 2024-03-31 | 70.09% | +10.82 pp |
| Q4 2023 | 2023-12-31 | 61.77% | +15.63 pp |
| Q3 2023 | 2023-09-30 | 61.85% | +19.40 pp |
| Q2 2023 | 2023-06-30 | 57.74% | +15.59 pp |
| Q1 2023 | 2023-03-31 | 59.27% | +17.21 pp |
| Q4 2022 | 2022-12-31 | 46.14% | +12.09 pp |
| Q3 2022 | 2022-09-30 | 42.46% | +19.28 pp |
| Q2 2022 | 2022-06-30 | 42.15% | +58.73 pp |
| Q1 2022 | 2022-03-31 | 42.06% | +9.94 pp |
| Q4 2021 | 2021-12-31 | 34.05% | +16.78 pp |
| Q3 2021 | 2021-09-30 | 23.18% | +40.69 pp |
| Q2 2021 | 2021-06-30 | −16.58% | — |
| Q1 2021 | 2021-03-31 | 32.12% | — |
| Q3 2020 | 2020-09-30 | 17.27% | — |
| Q2 2020 | 2020-06-30 | −17.52% | — |
Over the last five reported fiscal years, RxSight's gross margin increased from 11.62% to 76.60%, a change of +64.98 percentage points. The latest reported quarter, Q1 2026, shows 76.06%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review RxSight filings at SEC.gov ↗